Need for risk stratification in treatment of patients with autoimmune hepatitis.

Yang, Fan; Fan, Xiaoli; Zhou, Leyu; Yang, Li

Yang, Fan; Fan, Xiaoli; Zhou, Leyu; Yang, Li.

Affiliation

Yang F; Department of Gastroenterology and Hepatology and Laboratory of Gastrointestinal Cancer and Liver Diseases, West China Hospital of Sichuan University, Chengdu, China.
Fan X; Department of Gastroenterology and Hepatology and Laboratory of Gastrointestinal Cancer and Liver Diseases, West China Hospital of Sichuan University, Chengdu, China.
Zhou L; Department of Gastroenterology and Hepatology and Laboratory of Gastrointestinal Cancer and Liver Diseases, West China Hospital of Sichuan University, Chengdu, China.
Yang L; Department of Gastroenterology and Hepatology and Laboratory of Gastrointestinal Cancer and Liver Diseases, West China Hospital of Sichuan University, Chengdu, China. Electronic address: yangli_hx@scu.edu.cn.

J Hepatol ; 81(4): e202-e203, 2024 Oct.

Article in En | MEDLINE | ID: mdl-38734377

Subject(s)

Hepatitis, Autoimmune; Humans; Hepatitis, Autoimmune/drug therapy; Hepatitis, Autoimmune/diagnosis; Risk Assessment/methods

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis, Autoimmune Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google